Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by HighSkies2019 on Jun 04, 2020 5:54pm

NCT04306393

That's the clinical study we are under ... got this from kly may 27 nr...looks like we are in a phase 2 and drug is FDA approved ... testing administration method ... if I am reading it right
Comment by Newinvestor68 on Jun 04, 2020 6:36pm
Unfortunately, Kalyteras claim to fame is injection not inhalation. I hate the way they lead people on with their selection of words. I hope I am wrong but it doesn't look like this would help us. 
Comment by Newinvestor68 on Jun 04, 2020 6:44pm
Ok, I looked at a Kaly press release and it does mention inhalation.  The link to the full article is below but this is what I mean by misleading wording. This jumbled sentence makes it sound like they have a patent in 40 countries but read it slowly and they don't.  Salzman Group is the owner of R-107, a proprietary drug with issued and pending composition of matter and method ...more  
Comment by JMark80 on Jun 04, 2020 9:00pm
Issued or pending. Don't worry about it, patents are important but there are much bigger issues at hand.
Comment by Raiders11 on Jun 04, 2020 9:23pm
The inhalation is for chlorine related lung injuries,still an injection of the product to relieve the symptoms.
Comment by Raiders11 on Jun 04, 2020 9:28pm
Chemotherapy treatment's cause CILI,so it could have potential,bin in the works since 2011,so not a new concept.
Comment by JMark80 on Jun 04, 2020 6:40pm
That's not Kalytera's study, they just used that as an example of NO as treatment of COVID.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities